
    
      Treatment with other WT1 vaccines in clinical trials has shown evidence of immunogenicity and
      clinical response in various malignancies.

      This study will assist with determining which dose level(s) to use in future clinical studies
      and will evaluate both clinical and immunological response.
    
  